Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZhenQi FuZheng for Allergic Rhinitis
NCT06427577Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Open-label, single-arm trial of Zhenqi Fuzheng granules in allergic rhinitis (AR), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Rhinoconjunctivitis Quality of Life Questionnaire at 12 weeks and Visual Analog Score for pain at 12 weeks. Started Jun 2024; status: recruiting.
02
Drugs
Zhenqi Fuzheng granules
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06427577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06427577.